All your MA & HTA needs in one place.

About us

Find out more about our history, values and Team.
Explore

Offer

See how we turn clinical data into market access strategies.
Explore

Publications

Read our latest publications.
Explore

Team

MAHTA is first and foremost about people who are dedicated to their work and constantly improving their knowledge, skills and competence.

Meet our team

Partnership

The reason for our immense pride, but also the measurable effect of our daily work, is increased access to effective forms of treatment and improve the quality of life of patients worldwide.

Explore

Bespoke solutions

We support the companies we work with at all stages of the reimbursement process. We offer knowledge, experience and a professional, flexible approach so that the solutions we propose are appropriate, effective and efficient.

Explore

in numbers

400

Over 400

successfully completed

reimbursement processes.

covering HTA.

40

Cooperation with over

40 renowned

specialists from various

areas of expertise.

50

Over 50 international processes successfully implemented.

News

Services Based on Medical Devices – How to Implement Them into the Healthcare System in Poland.

On 28 November 2025, during the XXIII Conference of the Polish Society of Pharmacoeconomics, Session VIII will take place. ,,Services Based on Medical Devices – How to Implement Them into the Healthcare System in Poland”.
Explore

The Medical Fund and its Impact on Access to Treatment in Poland.

On 27 November 2025, during the XXIII Conference of the Polish Society of Pharmacoeconomics, Session V, ,,The Medical Fund and its Impact on Access to Treatment in Poland’’, will take place.
Explore

JCA in Poland and Europe – Initial Experiences and Future Directions / JCA and W.A.I.T. – Access to Treatment in Poland and Europe.

On 27 November 2025, during the XXIII Conference of the Polish Society of Pharmacoeconomics, Session II will be held: ,,JCA in Poland and Europe – Initial Experiences and Future Directions / JCA and W.A.I.T. – Access to Treatment in Poland and Europe’’.
Explore
Other news

Publications

Matching‑Adjusted Indirect Comparison of Osilodrostat Versus Metyrapone for the Treatment of Cushing’s Syndrome

Hickey C., Gueron B., Schmidt F., Tyas E., Binowski G., Pivonello R.
Open

Budget Impact Analysis of Risdiplam in the Treatment of Newborn Spinal Muscular Atrophy Patients in Poland

Strachota S., Malysiak-Szpond S., Binowski G., Książek P., Sutherland C.S., Pruszko C.
Open

Cost-Effectiveness of Glycopyrronium Bromide Oral Solution for the Management of Severe Sialorrhea in Children With Cerebral Palsy in Poland

Łabęcka D., Binowski G., Książek P., Rynkiewicz S., Pruszko C.
Open
Other publications